Faculty profile

Gonzalo Sapisochin

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Gonzalo Sapisochin

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
147 publications in the last five years, latest in 2026.
Senior (last) author on 63 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

256

Publications

354

Citations

h-index

191

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cell-Free Dna Clinical Genomics Genomics Hepatocellular Carcinoma Liver Cancer Translational Research Transplant

Latest papers

Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCC.
Cancer treatment reviews · 2026
Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026 · senior author
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.) · 2026

All 256 publications

Latest funding

Enhanced precision in hepatocellular carcinoma liver transplantation through cell-free genome and epigenome sequencing
CIHR · 2024 · Principal investigator
$1,300,500

All 1 grants and awards

From the 150 most recent of 256 publications.

Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCC.

Lim HJ, Vogel A, Dunne EM, Brahmania M, Tam VC, Abraham RJ, Knox JJ, Wong JK, Chaudhury P, Ramjeesingh R, Kim PTW, Martins I, Leite LC, Valenti D, Sapisochin G, Liu DM

Cancer treatment reviews2026

DOI: 10.1016/j.ctrv.2026.103194 PMID: 42492407

Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC.

Aceituno L, O'Kane GM, Choi WJ, Tarbizian P, Bucur R, Rukavina N, Zorigtbaatar A, Mínguez B, Vogel A, Sapisochin G

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2026Senior author

DOI: 10.1097/lvt.0000000000000829 PMID: 41855385

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

Singal AG, Agopian VG, Dawson LA, El-Khoueiry A, Finn RS, Halazun K, Heimbach JK, Kelley RK, Kim E, Kulik L, Mehta N, Mendiratta-Lala M, Meyer J, Parikh ND, Pillai A, Salem R, Sapisochin G, Tabrizian P, Yopp A, Yarchoan M, HCC-Live Steering Committee

Hepatology (Baltimore, Md.)2026

DOI: 10.1097/hep.0000000000001834 PMID: 42565685

Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.

Yarchoan M, Llovet JM, Kelley RK, Finn R, Parikh ND, Tabrizian P, Burgoyne AM, Agopian VG, Sanford NN, Tran Cao HS, Padia SA, Vogel A, Lewandowski RJ, Kirema GR, Lin R, Mehta N, Sapisochin G, Yopp A, Villanueva A, Halazun K, Pinato DJ, Kim E, Heimbach JK, Pillai A, Salem R, El-Khoueiry A, Singal AG

Gut2026

DOI: 10.1136/gutjnl-2026-339505 PMID: 42785981

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Gaspar C, Wu B, Stone SC, Sotov V, Wang B, Wangulu C, Berman H, Kay A, Basra P, Van de Laar E, Bratman S, Lheureux S, Knox J, Kim R, He H, Liu G, Bedard P, Spreafico A, Tsao M, Pugh TJ, Hansen A, Sapisochin G, Garcia ES, Siu LL, Bruce JP

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1876853 PMID: 42625601

Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396].

Choi WJ, Ivanics T, Claasen M, Magyar CTJ, Li Z, Tabrizian P, Rocha C, Myers B, O'Kane GM, Reig M, Fàbrega JF, Holguín V, Parikh ND, Pillai A, Hunold TM, Vogel A, Patel MS, Singal AG, Tadros M, Feld JJ, Hansen B, Sapisochin G

Surgery2026Senior author

DOI: 10.1016/j.surg.2026.110228 PMID: 42215358

Evolution of liver transplant systems.

Gravely AK, Kim P, Sapisochin G, Schmidt N

American journal of surgery2026

DOI: 10.1016/j.amjsurg.2026.116971 PMID: 41990628

Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model.

Li Z, Centonze L, Raptis D, Marquez KAH, Rammohan A, Gunasekaran V, Hong S, Chen IC, Kim J, Hsu SC, Kirimker EO, Akamatsu N, Shaked O, Finotti M, Yeow M, Genedy L, Dutkowski P, Nadalin S, Boehnert MU, Polak WG, Bonney GK, Mathur A, Samstein B, Emond JC, Testa G, Olthoff KM, Heimbach JK, Taner T, Wong TCL, Hasegawa K, Balci D, Cattral M, Sapisochin G, Selzner N, Jeng LB, Joh JW, Chen CL, Suh KS, Di Sandro S, Rela M, Broering D, Clavien PA

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society2026

DOI: 10.1097/lvt.0000000000000816 PMID: 41564353

Perioperative approaches for patients with biliary tract cancer.

Zorigtbaatar A, Li Z, Magyar CTJ, Aceituno L, Saborowski A, Vogel A, Grant RC, O'Kane GM, Sapisochin G

Nature reviews. Clinical oncology2026Senior author

DOI: 10.1038/s41571-026-01130-5 PMID: 41776242

The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver Cancer.

Kodali S, Kulik L, D'Alessio A, De Martin E, Hakeem AR, Lewinska M, Lindsey S, Liu K, Maravic Z, Patel MS, Pinato DJ, Rammohan A, Rich N, Sanduzzi Zamparelli M, Victor DW, Vinaxia C, Brombosz EW, Villanueva A, Meyer T, Selzner N, Ghobrial RM, Rela M, Sapisochin G, and the ILTSILCAconsensus2024 Group

Liver cancer2026Senior author

DOI: 10.1159/000550600 PMID: 42312290

Something wrong or missing on this profile? Suggest a correction

Gonzalo Sapisochin

Research

Latest papers

Latest funding

Expanding the path to cure - a narrative review on optimizing multimodality sequencing in HCC.

Beyond rejection risk: Identifying ideal candidates for pretransplant immune checkpoint inhibitors for HCC.

BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.

Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396].

Evolution of liver transplant systems.

Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model.

Perioperative approaches for patients with biliary tract cancer.

The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver Cancer.

Enhanced precision in hepatocellular carcinoma liver transplantation through cell-free genome and epigenome sequencing

Frequent collaborators

Anand Ghanekar

Nazia Selzner

Markus Selzner

Mamatha Bhat

Mark Cattral

Ian Mcgilvray

Arndt Vogel

Steven Gallinger

Cynthia Tsien

Gideon Hirschfield

Pablo Serrano Aybar

Michael Yan

Laura Dawson

Robert Grant

Rob Beecroft

Julie Hallet

Wei Xu

Faiyaz Notta

Atul Humar

Patrick Veit-Haibach

Osvaldo Espin Garcia

Anton Skaro

Jelena Lukovic

John Kim

Guillaume Martel

Nicola Jones

Deepali Kumar

Brandon Meyers

Yasmin Essaji

Harold Atkins

Surain Roberts

Lawrence Gillman

Michael Verret

Aklile Workneh

Alaa Rostom

David Allan

Jing Zhang

Lothar Huebsch

Philippe Bedard

Gianni Lorello